, and Paediatrics + cell dose and infused number of committed progenitor cells in transplantation are important factors in hematologic engraftment. However, the relationship between expansion potential of progenitor cells and hematologic engraftment remains controversial. We evaluated whether expansion potential of progenitor cells is a predictive factor of post-transplantation hematologic engraftment.
Methods : Mononuclear cells isolated from mobilized peripheral blood and bone marrow were cultured with cytokine cocktail for 7 days. Progenitor cells and committed progenitors were analyzed using stem cell markers (CD34 and CD133) and lineage specific markers. Hematologic engraftment was defined as neutrophil counts over 500/ L and platelet counts over 20,000/ L without transfusion. Acute and chronic graft-versus-host disease (GVHD) were investigated.
Results : There was inverse tendency between the number and fold expansion of progenitor cells or committed (granulocytic or megakaryocytic) progenitors and time to engraftment. Especially, fold expansion of CD34 + /CD33 + cells was significantly correlated with time to neutrophil engraftment in bone marrow transplantation (r=-0.56, P=0.04). The infused number and fold expansion of lymphoid progenitors were not related to the occurrence of acute or chronic GVHD.
Conclusions : We could not prove that expansion potential of progenitor cells and committed progenitor cells is correlated to hematologic engraftment although there is a correlation between CD34 + ation is defined by the expression pattern of surface markers. Antibodies to CD34 isolate the HSCs [1] . Recently, a new stem cell marker CD133 (AC133) was discovered as a strong candidate for primitive hematopoietic cells with repopulating activity [2] .
Hematopoietic stem cell transplantations are now a routine treatment modality in patients with various malignancies and disorders of the blood and immune system. But protracted severe neutropenia and thrombocytopenia until complete engraftment lead to serious bacterial or fungal infection and bleeding tendency which are major limitations of stem cell transplantation.
Two important components, HSCs and committed hematopoietic progenitor cells, are necessary for a successful transplantation of HSCs. These are required for long term engraftment and overcoming cytopenia after myeloablation. The number of CD34 + cells infused is an crucial factor predicting the rate of neutrophil and platelet recovery after stem cell transplantation [3, 4] . For optimal engraftment, current transplantation protocols call for 2.5
+ cells/kg of patient body weight [5] . Weaver et al. [6] reported that a dose of CD34 + cells equal to or more than 5×10 6 /kg can ensure neutrophil recovery within 7 to 10 days of infusion in autologous peripheral blood stem cell transplantation (PBSCT). In addition, a number of studies have shown that infused granulocyte-monocyte colony forming units (CFU-GM) are significantly associated with neutrophil engraftment and that there is a correlation between platelet engraftment and the number of megakaryocytic progenitor cells [7, 8] .
The purpose of this study was to evaluate the infused number and fold expansion of HSCs and committed progenitor cells which might be a predictive factor for hematologic recovery.
MATERIALS AND METHODS

Specimen collection and processing
Thirteen patients (non-Hodgkin's lymphoma in 6 and multiple myeloma in 7) who underwent autologous PBSCT and 14 allogeneic bone marrow transplantation (BMT)
were included in this study. Homogenous patients with lymphoma and multiple myeloma for PBSCT were chosen in order to minimize differences in the disease state, 
Ex vivo expansion using liquid culture
Low density mononuclear cells (MNCs) (<1.077 g/mL)
were separated by density gradient centrifugation (1,500 rpm, 30 min) using Histopaque 
Flow cytometry
The 
Patient monitoring after hematopoietic stem cell transplantation
Complete blood cell counts, including reticulocyte counts, were determined daily in all patients from the start of con- GVHD was analyzed by Mann-Whitney U test. P value below 0.05 was considered to be statistically significant. But these relationship were not statistically significant.
Statistical analysis
RESULTS
Frequency and expansion potential of progenitor cells
With BM, the days to neutrophil (r=-36, P=0.19) and platelet recovery (r=-50, P=0.07) were shorten in the group with a greater fold expansion of progenitor cells.
Fold expansion of CD34
+ /CD33 + showed a significant correlation with the days to neutrophil recovery (r=-0.56, P=0.04) (Fig. 2) Table 2 . Expansion potential of progenitor cells in mPB and BM without chronic GVHD, the group with chronic GVHD showed a higher fold expansion of lymphoid progenitor cells, but was not statistically significant (P=0.09, P=0.11) ( Table 4) .
DISCUSSION
In this study, we chose unselected MNCs instead of Some studies proposed adhesion molecules such as Lselectin, CD44 or a few integrins play an important role in hematologic reconstitution [22, 23] . This study did not analyze these adhesion molecules. There is a possibility that the correlation between expansion potential of committed progenitor cells and neutrophil or platelet engraftment was masked by the effect of adhesion molecules.
A small number of patients can be a major cause for the lack of statistical significance. Therefore, further studies Previous studies suggested that the depletion of T lymphoid cells from the donor bone marrow reduce acute GV-HD. But recent studies indicated that T cell depletion is less effective and that HLA disparity and ABO incompatibility increase acute GVHD risk [24] . In our study, the infused number of B-and T-lymphoid progenitor cells was not related to the development of a moderate to severe acute GVHD, and the expansion potential of lymphoid progenitor cells also showed no effect on the development of acute GVHD.
The pathophysiology of chronic GVHD is still poorly understood. It has not been determined whether chronic GVHD is a distinct entity or a continuation of acute GV-HD. One explanation is that expansion and effector functions of auto reactive T-cells will promote auto reactive B-cell activation and that production of auto antibodies will damage target organs [25] .
Although fold expansion of B-or T-lymphoid progenitors was higher in patients with chronic GVHD, the expansion potential of lymphoid progenitors was not related to the development of chronic GVHD. Also, the infused number of lymphoid progenitors displayed no effect on the development of chronic GVHD. These findings support the fact that infused doses or expansion potential of lymphoid progenitors might not be directly related to the development of acute or chronic GVHD.
In the present study, the total infused number of pro- 
